Nutriband Inc. (NTRB) Stock

Nutriband Inc. (NTRB) is a Healthcare stock trading at $3.02 (as of 2026-06-18), with a market capitalization of $49.92M and a trailing P/E of -1.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Nutriband Inc. develops transdermal pharmaceutical products, including an abuse-deterrent fentanyl transdermal system (AVERSA fentanyl) and other candidates such as AVERSA buprenorphine and AVERSA methylphenidate, along with exenatide for type 2 diabetes and follicle stimulating hormone for infertility. The company also holds a license agreement with Rambam Med-Tech Ltd. for development of RAMBAM Closed System Transfer Devices.

Valuation — source: SEC EDGAR (first-party)

Price	$3.02
Market Cap	$49.92M
P/E Ratio	-1.4
EV / EBITDA	0.6
Price / Sales	0.00

Profitability & Growth — source: SEC EDGAR

Revenue (TTM)	$2.04M
Net Margin	-404.1%
Return on Equity	-123.2%
Current Ratio	6.36
Revenue Growth (YoY)	-4.8%
EPS Growth (YoY)	160.6%
FCF Growth (YoY)	8.9%

Financial Health — source: SEC EDGAR

Altman Z-Score

-11.36 (distress)

Valuation vs Sector & Industry

Stock P/E	-1.4
Sector P/E (Healthcare)	21.0
Industry P/E (Medical Equipment)	31.7
vs Sector	-106.5%
vs Industry	-104.3%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures

Top Institutional Holder	VANGUARD GROUP INC ($920431.00)
Institutional Holders Tracked	10

Company

Sector	Healthcare
Industry	Medical Equipment
CEO	Gareth Sheridan
Employees	13
Country	US
IPO Date	2021-10-01

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

• Prenetics Global Limited (PRE)
• Plus Therapeutics, Inc. (PSTV)
• Outset Medical, Inc. (OM)
• Sensus Healthcare, Inc. (SRTS)
• HeartBeam, Inc. (BEAT)
• Modular Medical, Inc. (MODD)
• Nephros, Inc. (NEPH)
• NeurAxis, Inc. (NRXS)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.